🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999
This is a double-blind, randomized, placebo-controlled, parallel study. The...
Status
Unknown
Location
Chung-Ho Memorial Hospital, Kaohsiung Medical University:
Start Date
2018-11-09
Trial ID
NCT04342949
Treatments Being Tested
The purpose of this study is to assess if adding revumenib to standard chem...
Status
Recruiting
Location
Clinical Trial Site
Start Date
2025-11-25
Trial ID
NCT07211958
Treatments Being Tested
This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Status
Recruiting
Location
The fourth hospital of Hebei Medical University
Start Date
2024-11-15
Trial ID
NCT06576921
Treatments Being Tested
The GI-4000 therapeutic vaccine or placebo will be injected under the skin ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2006-01
Trial ID
NCT00300950
Treatments Being Tested
To test the hypothesis that the predominant accrual of fat rather than lean...
Status
Completed
Location
USC CRS
Start Date
TBD
Trial ID
NCT00001079
Treatments Being Tested
The aim of this study is to evaluate the synergistic anti-tumor effect of C...
Status
Unknown
Location
Jiege Huo
Start Date
2015-06
Trial ID
NCT02510118
Treatments Being Tested
RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
Royal Bournemouth Hospital
Start Date
2007-06
Trial ID
NCT00492258
Treatments Being Tested
This Phase 3 study was a randomized, double-blind, placebo-controlled, mult...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2019-07-22
Trial ID
NCT04005716
Treatments Being Tested
The primary objective of the study is to demonstrate superiority of rimonab...
Status
Withdrawn
Location
Sanofi-Aventis Administrative Office
Start Date
2008-09
Trial ID
NCT00754689
Treatments Being Tested